Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Jazz Pharmaceuticals at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Jazz Pharmaceuticals exhibits at Booth 3429 at ASH 2026 in New Orleans. Jazz Pharmaceuticals supports a symposium on how to sequence treatment in acute lymphoblastic leukemia. Experts debate choices from asparaginase to cellular therapy, with minimal residual disease results steering decisions.

OrganizationASH 2026 Attendance
Jazz Pharmaceuticals
Dublin, Ireland
jazzpharma.com
Large pharma1 exhibitor meeting room
Biopharmaceutical company with marketed medicines and pipeline candidates in neuroscience and oncology, including hematologic cancers.
Booth
Exhibiting at Booth 3429
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
3:00pm–6:00pm
Medical Crossfire®: Strategic Sequencing in ALL — From Asparaginase to Cellular Therapy in an MRD-Driven Era
Ordering acute lymphoblastic leukemia therapies, from asparaginase to bispecifics and CAR-T, guided by sensitive residual disease testing.
Convention Center · La Nouvelle A-B
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Jazz Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction